{"id":857,"date":"2025-09-02T22:21:44","date_gmt":"2025-09-02T20:21:44","guid":{"rendered":"https:\/\/www.nanoprogress.eu\/?post_type=clenove&p=857"},"modified":"2025-09-02T22:22:46","modified_gmt":"2025-09-02T20:22:46","slug":"bioinova-a-s","status":"publish","type":"clenove","link":"https:\/\/www.nanoprogress.eu\/en\/clenove\/bioinova-a-s\/","title":{"rendered":"Bioinova, a.s."},"content":{"rendered":"
\n
\n
\"\"<\/figure>\n\n\n
\r\n

Bioinova, a.s.<\/h3>\r\n \r\n
\r\n

V\u00edde\u0148sk\u00e1 119, <\/p>\n

619 00 Brno<\/p>\n

info@bioinova.cz<\/a>\u00a0
\u00a0+420 241 063 352<\/a><\/p>\n

www.bioinova.cz<\/a><\/p>\n <\/div>\r\n <\/div>\r\n <\/div>\n\n\n\n

\n

Bioinova, a.s. is a renowned Czech biotechnology company that specializes in the research, development, and production of cell therapies, with a focus on mesenchymal stem cells. The company was founded as a spin-off from research institutions and, since its inception, has established itself as a key player in the field of modern therapy in the Czech Republic. It focuses primarily on therapeutic applications in orthopedics, neurology, and dermatology, where it develops personalized medicinal products designed to regenerate damaged tissues, accelerate healing, or alleviate inflammatory conditions.<\/p>\n\n\n\n

Bioinova operates its own laboratories that comply with Good Manufacturing Practice (GMP) standards, holds a license from the State Institute for Drug Control (S\u00daKL), and participates in several clinical trials in the Czech Republic. An important part of its activities is the translation of scientific knowledge into practice\u2014that is, directly linking research to clinical application. The company works closely with university hospitals, research institutes, and universities, and actively participates in the development of new treatment methods and the validation of therapeutic protocols.<\/p>\n\n\n\n

Thanks to its expertise, professional background, and strong focus on quality and safety, Bioinova is one of the pioneers in the field of cell therapy in Central Europe.<\/p>\n\n\n\n

\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Areas of activity<\/h2>\n\n\n\n
    \n
  • Development and production of medicinal products based on mesenchymal stem cells<\/li>\n<\/ul>\n\n\n\n
      \n
    • Applications of cell therapies in orthopedics, neurology and dermatology<\/li>\n<\/ul>\n\n\n\n
        \n
      • Clinical trials and approval of products in the ATMP regime<\/li>\n<\/ul>\n\n\n\n
          \n
        • Translation of scientific knowledge into medical practice<\/li>\n<\/ul>\n\n\n\n
            \n
          • Collaboration with hospitals, research institutions and academia<\/li>\n<\/ul>\n\n\n\n

            Bioinova, a.s.<\/strong> develops stem cell therapies for regenerative medicine and clinical applications in orthopedics, neurology, and dermatology.<\/p>\n\n\n\n

            <\/h2>\n\n\n\n

            <\/p>\n<\/div>\n\n\n\n

            \n
            \"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

            <\/p>","protected":false},"featured_media":859,"template":"","typ_clena":[21],"class_list":["post-857","clenove","type-clenove","status-publish","has-post-thumbnail","hentry","typ_clena-prumyslove-firmy"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nanoprogress.eu\/en\/wp-json\/wp\/v2\/clenove\/857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nanoprogress.eu\/en\/wp-json\/wp\/v2\/clenove"}],"about":[{"href":"https:\/\/www.nanoprogress.eu\/en\/wp-json\/wp\/v2\/types\/clenove"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nanoprogress.eu\/en\/wp-json\/wp\/v2\/media\/859"}],"wp:attachment":[{"href":"https:\/\/www.nanoprogress.eu\/en\/wp-json\/wp\/v2\/media?parent=857"}],"wp:term":[{"taxonomy":"typ_clena","embeddable":true,"href":"https:\/\/www.nanoprogress.eu\/en\/wp-json\/wp\/v2\/typ_clena?post=857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}